Skip to main content

Table 1 Baseline characteristics and lipid profiles in patients with and without coronary heart disease

From: Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease

 

Coronary heart disease (n = 419)

Noncoronary heart disease (n = 105)

P value

eGFR (ml/min·1.73 m2)

84.88 ± 24.61

79.88 ± 30.356

0.105

Sex (male/female)

328/91

77/28

0.170

Age (years)

58.72 ± 11.02

57.16 ± 12.67

0.26

BMI (kg/m2)

24.34 ± 0.24

24.48 ± 0.47

0.777

Smoking (%)

50.12

36.19

0.008

Hypertension (%)

56.56

62.86

0.270

Diabetes (%)

24.10

20.00

0.439

Systolic BP when Admitted (mmHg)

134.18 ± 37.24

133.05 ± 24.68

0.768

Diastolic BP when Admitted (mmHg)

79.89 ± 13.72

80.74 ± 14.97

0.574

CR (чmol/L)

90.47 ± 31.53

95.64 ± 40.00

0.157

Cys-C(mmol/L)

1.27 ± 0.07

1.10 ± 0.03

0.513

CRP (mg/L)

16.51 ± 1.65

15.07 ± 2.89

0.681

TG (mmol/L)

1.79 ± 0.05

1.63 ± 0.10

0.195

TC (mmol/L)

4.62 ± 0.06

4.64 ± 0.12

0.838

HDL-C (mmol/L)

0.96 ± 0.01

1.09 ± 0.03

0.000

LDL-C (mmol/L)

2.93 ± 0.04

2.92 ± 0.09

0.905

apoA-I (g/L)

1.12 ± 0.01

1.18 ± 0.02

0.001

apoB (g/L)

1.06 ± 0.10

0.96 ± 0.02

0.615

Lp(a) (g/L)

0.31 ± 0.01

0.25 ± 0.02

0.012

apoE (mg/L)

46.64 ± 0.80

46.27 ± 1.48

0.835

HDL-C/apoA-I

0.85 ± 0.13

0.92 ± 0.20

0.005

  1. BMI, Body mass index; BP, Blood Pressure